Incidental detection of malignancy during preprocedural workup for transcatheter aortic valve implantation: A longitudinal cohort study.
- Resource Type
- Editorial & Opinion
- Authors
- Demirel C; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.; Tomii D; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.; Heg D; CTU Bern, University of Bern, Bern, Switzerland.; Okuno T; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.; Wieser F; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.; Suter TM; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.; Gräni C; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.; Windecker S; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.; Pilgrim T; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland. Electronic address: thomas.pilgrim@insel.ch.
- Source
- Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE
- Subject
- Language
- English
The aim of this retrospective analysis was to investigate the prevalence and prognostic importance of incidental malignancy detected during pre-TAVI computed tomography. Among 579 patients, CT-work-up for TAVI exposed previously undetected malignancy in 4.5% of patients. TAVI patients with a new malignancy had a 2.9-fold increased risk of death at 1 year, and a 16 month shorter mean survival time compared to patients with no malignancy.
(Copyright © 2023 Elsevier Inc. All rights reserved.)